Covid-19 Archives - United Academics Magazine

Covid-19 Vaccines: A Timeline of Recent Advancements 0
- Covid-19, Flash News
- November 26, 2020
Images Credit: Mos.ru, CC BY 4.0, via Wikimedia Commons, Rs-nourse, CC BY-SA 4.0, via Wikimedia Commons,https://en.wikipedia.org/wiki/File:Moderna_Therapeutics_company_logo.png with UploadWizard, CC BY-SA 3.0 Press Releases: Sputnik: https://sputnikvaccine.com/newsroom/pressreleases/second-interim-analysis-of-clinical-trial-data-showed-a-91-4-efficacy-for-the-sputnik-v-vaccine-on-d/ AstraZeneca: https://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine FDA: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-announces-advisory-committee-meeting-discuss-covid-19-vaccine Pfizer: https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine Moderna: https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy

READ MORE
The First Record of a SARS-CoV2 Infection Dates to One Year Ago Today 0
- Covid-19, Flash News
- November 17, 2020
A 55-year-old resident of Hubei, China, may have been the first registered case of the novel coronavirus infection. The record dates to one year ago today, on the 17th of November 2019, according to Chinese official data revealed by The South China Morning Post. But the search for “patient zero” is far from over. Without

READ MORE
Pfizer’s Vaccine Offers Protection against Covid19, According to Early Data 0
- Covid-19, Flash News
- November 9, 2020
Pfizer’s mRNA-based vaccine candidate shows initial evidence of protection against Covid-19, the American pharmaceutical company announced today. Preliminary data from the phase 3 vaccine trials, which began on July 27, indicates the vaccine has a 90% efficacy rate in preventing Covid-19 in participants without prior evidence of Sars-Cov2 infection. The trial is taking place in

READ MORE

Covid-19 Candidate Vaccines Pass Safety and Efficacy Tests 0
- Covid-19, Health & Medicine
- July 23, 2020
Two candidate vaccines (ChAdOx1 and Ad-5-nCoV) for Covid-19 have been shown to be safe and efficacious in humans, according to two studies published this week in The Lancet journal. Both vaccines are based on adenovirus vectors, DNA viruses that act as vehicles to carry SARS-CoV-2 proteins to the body, therefore eliciting a response against an

READ MORE
Asymptomatic Patients Appear to Have Lung Damage and Low Antibody Levels after SARS-CoV-2 Infection 0
- Covid-19
- June 25, 2020
The levels of antibody protection against SARS-CoV-2 infection may not last longer than a few months, reveals an article published last week on Nature Medicine. Of 37 people with a positive test for SARS-CoV-2 but with no clinical symptoms of the disease, 81% tested positive for IgG, an antibody produced 3 to 4 weeks after

READ MORE
Using Artificial Intelligence to Diagnose COVID19 0
- Covid-19, Design & Technology
- May 21, 2020
The novel coronavirus, SARS-CoV-2, was first identified in Wuhan, China, in December 2019 and since then it has emerged as a global pandemic. More than 5 million people have been infected globally across 187 countries and over 320,000 people lost their lives to it (1). Because COVID19 (coronavirus disease) is a highly contagious and potentially

READ MORE